Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

NBT Q1 Profit Declines, Yet Beats View By A Penny

NBT Bancorp Inc. (NBTB: Quote), a financial holding company, Monday said its first-quarter profit declined 5 percent to $13.7 million from $14.3 million in the year-ago quarter. On a per share basis, earnings were $0.41, flat with last year.

On average, four analysts polled by Thomson Reuters expected the company to earn $0.40 per share for the first quarter. Analysts' estimates typically exclude special items.

Net-interest income increased slightly to $49.4 million from $49.3 million last year. Non-interest income for the period was $23.1 million, up 14.6 percent from $20.1 million last year.

Net-interest margin was 3.90 percent, down 21 basis points from 4.11 percent last year.

Click here to receive FREE breaking news email alerts for NBT Bancorp Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Amazon.com, Inc. said Thursday that its second quarter loss widened from last year, as operating expenses outpaced revenue growth amid heavy spending on new technology and contents. The company's quarterly loss per share was also wider than what analysts expected, but is quarterly sales came in line with analysts' forecast. The company also forecast an operating loss for the current quarter. After failing to sustain an initial upward move, stocks showed a lack of direction throughout much of the trading day on Thursday. The major averages eventually closed nearly unchanged, turning in a mixed performance for the second straight day. New home sales in the U.S. showed a notable decrease in the month of June, according to a report released by the Commerce Department on Thursday, with the steep drop offsetting the jump seen in the previous month.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.